Lucid Diagnostics (LUCD) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 0.49.
- Lucid Diagnostics' Equity Ratio rose 7315.34% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year increase of 7315.34%. This contributed to the annual value of 0.18 for FY2024, which is 30711.14% up from last year.
- Lucid Diagnostics' Equity Ratio amounted to 0.49 in Q3 2025, which was up 7315.34% from 0.2 recorded in Q2 2025.
- Lucid Diagnostics' 5-year Equity Ratio high stood at 0.8 for Q2 2022, and its period low was 0.16 during Q1 2025.
- Its 4-year average for Equity Ratio is 0.38, with a median of 0.37 in 2024.
- As far as peak fluctuations go, Lucid Diagnostics' Equity Ratio surged by 30711.14% in 2024, and later crashed by 14417.79% in 2025.
- Lucid Diagnostics' Equity Ratio (Quarter) stood at 0.71 in 2022, then crashed by 111.95% to 0.08 in 2023, then skyrocketed by 307.11% to 0.18 in 2024, then soared by 176.69% to 0.49 in 2025.
- Its Equity Ratio was 0.49 in Q3 2025, compared to 0.2 in Q2 2025 and 0.16 in Q1 2025.